Suchergebnisse - "Pulmonary Fibrosis"

PubPharm (16.316)

31

Protective effects of microbial biosurfactants produced by Bacillus halotolerans and Candida parapsilosis on bleomycin-induced pulmonary fibrosis in mice : Impact of antioxidant, anti-inflammatory and anti-fibrotic properties via TGF-β1/Smad-3 pathway and miRNA-326

enthalten in: Toxicology and applied pharmacology | 2024

von Mousa, A. | Nooman, M. | Abbas, S. | +3

32

Pharmacological inhibition of the ACE/Ang-2/AT1 axis alleviates mechanical ventilation-induced pulmonary fibrosis

enthalten in: International immunopharmacology | 2024

von Feng, J. | Huang, X. | Xu, Q. | +7

33

Prevalence and prognostic meaning of interstitial lung abnormalities in remote CT scans of patients with interstitial lung disease treated with antifibrotic therapy

enthalten in: Radiologia | 2024

von García Mullor, M. | Arenas-Jiménez, J. | Ureña Vacas, A. | +4

34

Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients : Real-World Medication Adherence Trajectories to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients

enthalten in: ClinicalTrials.gov | 2024

35

Predictive factors for dose reduction and discontinuation of nintedanib in fibrotic interstitial lung diseases : Real life data

enthalten in: Respiratory medicine | 2024

von Costa, E. | Pedroso, A. | Matos, R. | +4

36

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis : A Phase III Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis

enthalten in: ClinicalTrials.gov | 2024

37

Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions : POST COvid-19 Interstitial Lung DiseasE (POSTCODE) A Study of Genetic and Environmental Interactions: an Observational Cohort Study.

enthalten in: ClinicalTrials.gov | 2024

38

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease : A Two-Cohort, Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy and Safety of Vixarelimab Compared With Placebo in Patients With Idiopathic Pulmonary Fibrosis and in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease

enthalten in: ClinicalTrials.gov | 2024

39

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) : A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

enthalten in: ClinicalTrials.gov | 2024

40

The Effect Of Baduanjin Exercises In Patients With Idiopathic Pulmonary Fibrosis : The Effect Of Baduanjin Exercises On Functional Capacity, Respiratory Functions And Quality Of Life In Patients With Idiopathic Pulmonary Fibrosis: a Randomized Controlled Study

enthalten in: ClinicalTrials.gov | 2024